Search company, investor...

Kytogenics Pharmaceuticals Limited

Founded Year



Unattributed VC | Alive

Total Raised


Last Raised

$2.48M | 20 yrs ago

About Kytogenics Pharmaceuticals Limited

Kytogenics is a medical device company. It had developed the Nocc Hydrophilic Wound Dressing.Kytogenics Pharmaceuticals, Inc. is a biomedical company engaged in the development of products based on its medical device and drug delivery patented platform technology.

Headquarters Location

466 Southern Blvd. Adams Building, First Floor

Chatham, New Jersey, 07928,

United States


Missing: Kytogenics Pharmaceuticals Limited's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Kytogenics Pharmaceuticals Limited's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Kytogenics Pharmaceuticals Limited Patents

Kytogenics Pharmaceuticals Limited has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Polysaccharides, Biomaterials, EC 2.4.1, EC 3.2.1, Carbohydrates


Application Date


Grant Date



Related Topics

Polysaccharides, Biomaterials, EC 2.4.1, EC 3.2.1, Carbohydrates



Kytogenics Pharmaceuticals Limited Frequently Asked Questions (FAQ)

  • When was Kytogenics Pharmaceuticals Limited founded?

    Kytogenics Pharmaceuticals Limited was founded in 1991.

  • Where is Kytogenics Pharmaceuticals Limited's headquarters?

    Kytogenics Pharmaceuticals Limited's headquarters is located at 466 Southern Blvd., Chatham.

  • What is Kytogenics Pharmaceuticals Limited's latest funding round?

    Kytogenics Pharmaceuticals Limited's latest funding round is Unattributed VC.

  • How much did Kytogenics Pharmaceuticals Limited raise?

    Kytogenics Pharmaceuticals Limited raised a total of $2.48M.

  • Who are the investors of Kytogenics Pharmaceuticals Limited?

    Investors of Kytogenics Pharmaceuticals Limited include BDC Venture Capital, NSBI Venture Capital and Innovacorp.

  • Who are Kytogenics Pharmaceuticals Limited's competitors?

    Competitors of Kytogenics Pharmaceuticals Limited include Adhezion Biomedical, Combinent BioMedical Systems, Supernus Pharmaceuticals, Wilmington Pharmaceuticals, Middlebrook Pharmaceuticals and 12 more.

Compare Kytogenics Pharmaceuticals Limited to Competitors

Advent Pharmaceuticals

Advent Pharmaceuticals is a specialty pharmaceutical company focused on developing inhaled drug products using a dry powder inhalation delivery system. The products are mostly used for the treatment of asthma and other respiratory diseases.

Piedmont Pharmaceuticals

Piedmont is a specialty pharmaceutical company focused on human and animal health therapeutics with expertise in parasitology and drug delivery systems.

IVREA Pharmaceuticals

IVREA Pharmaceuticals is a specialty pharmaceutical company focused on clinical development and commercialization of novel prescription pharmaceuticals for the treatment of dermatologic conditions. IVREA's pharmaceuticals leverage topical delivery technologies.

ENTRA Pharmaceuticals

ENTRA Pharmaceuticals is a specialty pharmaceutical company developing therapies and improving existing treatments in areas with high unmet medical needs. In addition to the company's technology platform, ENTRA possesses strong expertise in preclinical and clinical drug development and commercialization.

Intarcia Therapeutics

Intarcia Therapeutics is a biopharmaceutical company based in Boston, Massachusetts. Intarcia is engaged in the development of a pipeline of products for the proprietary Medici Drug Delivery System comprised of three technologies: A stabilization technology that allows for proteins, peptides, antibody fragments, and other highly potent small molecules to be stabilized at or above human body temperatures, a matchstick-sized osmotic mini-pump that is placed under the dermal layer of skin to deliver a continuous and consistent flow of medication, and a placement technology including proprietary tools designed to provide an optimal user experience.


Naryx Pharma is focused on development of its product candidates of inhaled, nebulized, intranasal drug formulations.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.